Ferreira Junior, Nilson Carlos 
; Pereira, Maurício dos Santos; Guimarães, Francisco Silveira ; Del Bel, Elaine Aparecida
Source: Neurotoxicity Research. Unidades: FMRP, FORP
Subjects: RECEPTORES, CANABINOIDES, INFLAMAÇÃO, DOENÇA DE PARKINSON
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA JUNIOR, Nilson Carlos et al. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia. Neurotoxicity Research, v. 37, n. 1, p. 12-29, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12640-019-00109-8. Acesso em: 23 jan. 2026.APA
Ferreira Junior, N. C., Pereira, M. dos S., Guimarães, F. S., & Del Bel, E. A. (2020). Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia. Neurotoxicity Research, 37( 1), 12-29. doi:10.1007/s12640-019-00109-8NLM
Ferreira Junior NC, Pereira M dos S, Guimarães FS, Del Bel EA. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia [Internet]. Neurotoxicity Research. 2020 ; 37( 1): 12-29.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s12640-019-00109-8Vancouver
Ferreira Junior NC, Pereira M dos S, Guimarães FS, Del Bel EA. Cannabidiol and cannabinoid compounds as potential strategies for treating Parkinson’s disease and l-DOPA-induced dyskinesia [Internet]. Neurotoxicity Research. 2020 ; 37( 1): 12-29.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1007/s12640-019-00109-8
